Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Racial differences in premenopausal endogenous hormones.

Simone P Pinheiro1, Michelle D Holmes, Michael N Pollak

  • 1Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA. n2spp@channing.harvard.edu

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
|September 21, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metformin modifies hormone changes associated with androgen deprivation therapy for prostate cancer.

Endocrine oncology (Bristol, England)·2026
Same author

Planetary Health Diet Index and breast cancer risk.

British journal of cancer·2026
Same author

Circulating levels of insulin-like growth factor binding protein 7 are associated with risks of chronic diseases and death.

npj aging·2026
Same author

Appetite, Obesity, Metabolism, and Malignancy: Do Incretin-Mimetic Drugs Reduce Cancer Risk?

Cancer prevention research (Philadelphia, Pa.)·2026
Same author

Development and Validation of Claims-Based Algorithms for Non-Melanoma Skin Cancer in Patients With Psoriasis Using Optum Market Clarity.

Pharmacoepidemiology and drug safety·2026
Same author

A High-Fiber, Plant-Based Diet in Myeloma Precursor Disorders: Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model.

Cancer discovery·2025

Racial differences in breast cancer risk are linked to varying premenopausal hormone levels. African American women showed higher estradiol and IGF-I, while Asian American women had higher free estradiol and IGF-I compared to Caucasians.

Area of Science:

  • Endocrinology
  • Oncology
  • Epidemiology

Background:

  • Breast cancer incidence varies significantly across racial groups, with African Americans exhibiting higher premenopausal rates and Asians having lower overall rates.
  • Endogenous hormones and growth factors are established risk factors for breast cancer, but their racial variations are not fully understood.

Purpose of the Study:

  • To investigate whether premenopausal endogenous hormone and growth factor levels differ by race.
  • To explore the association between race and key breast cancer risk factors, including estradiol, progesterone, prolactin, sex hormone-binding globulin (SHBG), insulin-like growth factor-I (IGF-I), and IGFBP-3.

Main Methods:

  • A cross-sectional study was conducted using data from the Nurses' Health Study II.
  • Hormone and growth factor levels were assayed in 111 African American, 111 Asian American, and 111 matched Caucasian women.

Related Experiment Videos

  • Robust linear regression was employed to analyze the association between race and hormone levels, controlling for potential confounders.

    • Main Results:

    • African Americans had significantly higher levels of estradiol, free estradiol, and IGF-I, along with lower SHBG and IGFBP-3, compared to Caucasians.
    • Asian Americans showed higher calculated free estradiol and free IGF-I, and lower SHBG levels relative to Caucasians.
    • No significant racial differences were observed for progesterone and prolactin levels.

    Conclusions:

    • Hormonal profiles in African Americans align with increased breast cancer risk compared to Caucasians.
    • Hormonal profiles in Asian Americans present an inconsistent association with breast cancer risk when compared to Caucasians.
    • Further research is warranted to elucidate racial disparities in endogenous hormones and their definitive link to breast cancer etiology.